List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 45 studies with search of: "Hydromorphone"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Fasting Study of Hydromorphone Hydrochloride 8 mg Tablets and Dilaudid 8 mg Tablets
Condition: Healthy
Interventions: Drug: Hydromorphone Hydrochloride tablet 8 mg;   Drug: Dilaudid® tablet 8 mg
2 Completed A Study on Efficacy (Effectiveness), Safety, and Impact on Quality of Life Measures of Dilaudid CR (Controlled Release);, Hydromorphone HCl in Patients With Chronic Low Back Pain
Condition: Low Back Pain
Intervention: Drug: OROS® hydromorphone HCL; Dilaudid CR (controlled release); Dilaudid IR (immediate release) as rescue medicine
3 Completed Comparison of Side Effects of Morphine and Hydromorphone PCA
Conditions: Post Operative Pain;   Post Operative Side Effects of Narcotic Pain Medications
Interventions: Drug: Morphine PCA;   Drug: Hydromorphone PCA
4 Completed An Open-Label Evaluation of the Dose Proportionality of OROS® Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg
Condition: Analgesia
Intervention: Drug: OROS® Hydromorphone HCL; OROS® Dilaudid; Dilaudid SR (slow release); Naltrexone (an opioid antagonist).
5 Active, not recruiting Safety Study of Intravenous Hydromorphone Using Incremental 1mg Doses up to 2mg for Adult ED Patients
Condition: Pain
Intervention: Drug: Hydromorphone
6 Completed An Open-Label Evaluation of the Independent Effects of Coadministration of a High-Fat Meal and Naltrexone Blockade on the Pharmacokinetic Profile of Dilaudid OROS (Hydromorphone HCI) 16mg
Condition: Analgesia
Intervention: Drug: Hydromorphone HCL 16mg; Dilaudid SR 16mg; Naltrexone (opioid antagonist) 50mg.
7 Completed Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-Release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain
Condition: Pain
Intervention: Drug: OROS Hydromorphone HCI SR (slow release)
8 Recruiting An Open-Label Study of Hydromorphone Oral Solution in Subjects Aged 28 Days to 16 Years for Postoperative Pain
Condition: Acute Pain
Intervention: Drug: Hydromorphone HCl
9 Active, not recruiting Safety and Efficacy Study of Hydromorphone and Morphine
Condition: Pain
Intervention: Drug: Morphine and Hydromorphone
10 Completed Safety of Hydromorphone in Adult Patients Presenting to the Emergency Department With Acute Severe Pain
Condition: Acute Pain
Intervention: Drug: Hydromorphone 2mg intravenous
11 Active, not recruiting Protocolized vs Nonprotocolized Treatment of Adult ED Patients With Acute Severe Pain
Condition: Acute Pain
Interventions: Drug: Hydromorphone;   Drug: Nonprotocolized
12 Completed Safety and Tolerability of Long-Term Administration of OROS Hydromorphone HCI (Slow Release) in Cancer Pain
Conditions: Pain;   Analgesics, Opioid
Intervention: Drug: OROS hydromorphone HCI (slow release)
13 Completed Safety, Effectiveness, and Impact on Quality of Life on Long-Term Administration of OROS Hydromorphone Slow-Release in Patients With Chronic Low Back Pain
Condition: Low Back Pain
Intervention: Drug: OROS hydromorphone HCI SR (slow release)
14 Recruiting Protocolized vs Discretionary Use of Opioids in Acute Pain
Condition: Pain
Interventions: Drug: Hydromorphone;   Drug: IV opioid
15 Completed A Study of the Effectiveness and Safety of Sustained-Release Hydromorphone (a Strong Opioid) in Patients With Chronic Noncancer Pain.
Condition: Pain
Intervention: Drug: hydromorphone
16 Not yet recruiting Ketamine and Hydromorphone for Patient Controlled Pain Relief in Children's Mucositis
Condition: Mucositis
Intervention: Drug: Ketamine & hydromorphone
17 Not yet recruiting Evaluation of Clinical Usefulness of Hydromorphone OROS in Korean Cancer Patients.
Condition: Pain
Intervention: Drug: Hydromorphone Hydrochloride
18 Recruiting Trial Comparing Morphine to Hydromorphone in Elderly Patients With Severe Pain
Condition: Acute Pain
Interventions: Drug: Morphine 0.05 mg/kg Intravenous;   Drug: Hydromorphone 0.0075 mg/kg intravenous
19 Not yet recruiting This is a Randomised, Open-Labeled, Multi-Center Study to Investigate the Safety and Efficacy of OROS Hydromorphone HCL Comparing With Morphine SR (Sustain Release) in Cancer Pain Patients.
Condition: Pain
Intervention: Drug: OROS hydromorphone
20 Completed An Effectiveness, Safety and Quality of Life Measures With Hydromorphone HCL, Dilaudid CR (Controlled Release)
Conditions: Osteoarthritis, Knee;   Osteoarthritis, Hip
Intervention: Drug: OROS hydromorphone HCL ; OxyContin

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services